FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3135098981> ?p ?o ?g. }

• W3135098981 endingPage "208" @default.
• W3135098981 startingPage "197" @default.
• W3135098981 abstract "Rationale: Disease activity in idiopathic pulmonary fibrosis (IPF) remains highly variable, poorly understood, and difficult to predict. Objectives: To identify a predictor using short-term longitudinal changes in gene expression that forecasts future FVC decline and to characterize involved pathways and cell types. Methods: Seventy-four patients from COMET (Correlating Outcomes with Biochemical Markers to Estimate Time-Progression in IPF) cohort were dichotomized as progressors (≥10% FVC decline) or stable. Blood gene-expression changes within individuals were calculated between baseline and 4 months and regressed with future FVC status, allowing determination of expression variations, sample size, and statistical power. Pathway analyses were conducted to predict downstream effects and identify new targets. An FVC predictor for progression was constructed in COMET and validated using independent cohorts. Peripheral blood mononuclear single-cell RNA-sequencing data from healthy control subjects were used as references to characterize cell type compositions from bulk peripheral blood mononuclear RNA-sequencing data that were associated with FVC decline. Measurements and Main Results: The longitudinal model reduced gene-expression variations within stable and progressor groups, resulting in increased statistical power when compared with a cross-sectional model. The FVC predictor for progression anticipated patients with future FVC decline with 78% sensitivity and 86% specificity across independent IPF cohorts. Pattern recognition receptor pathways and mTOR pathways were downregulated and upregulated, respectively. Cellular deconvolution using single-cell RNA-sequencing data identified natural killer cells as significantly correlated with progression. Conclusions: Serial transcriptomic change predicts future FVC decline. An analysis of cell types involved in the progressor signature supports the novel involvement of natural killer cells in IPF progression." @default.
• W3135098981 created "2021-03-15" @default.
• W3135098981 creator A5004691068 @default.
• W3135098981 creator A5006650120 @default.
• W3135098981 creator A5009091055 @default.
• W3135098981 creator A5010100677 @default.
• W3135098981 creator A5017089109 @default.
• W3135098981 creator A5019589703 @default.
• W3135098981 creator A5044514129 @default.
• W3135098981 creator A5051732204 @default.
• W3135098981 creator A5058325633 @default.
• W3135098981 creator A5062525504 @default.
• W3135098981 creator A5065857269 @default.
• W3135098981 creator A5069296013 @default.
• W3135098981 creator A5073728339 @default.
• W3135098981 creator A5080609457 @default.
• W3135098981 creator A5082568705 @default.
• W3135098981 creator A5086014788 @default.
• W3135098981 creator A5088823841 @default.
• W3135098981 creator A5089726431 @default.
• W3135098981 date "2021-07-15" @default.
• W3135098981 modified "2023-10-18" @default.
• W3135098981 title "Blood Transcriptomics Predicts Progression of Pulmonary Fibrosis and Associated Natural Killer Cells" @default.
• W3135098981 cites W1829632160 @default.
• W3135098981 cites W1954728404 @default.
• W3135098981 cites W1992767404 @default.
• W3135098981 cites W1998107112 @default.
• W3135098981 cites W2002762216 @default.
• W3135098981 cites W2006617902 @default.
• W3135098981 cites W2012442228 @default.
• W3135098981 cites W2055609841 @default.
• W3135098981 cites W2081098333 @default.
• W3135098981 cites W2081758257 @default.
• W3135098981 cites W2097360283 @default.
• W3135098981 cites W2098305693 @default.
• W3135098981 cites W2108280422 @default.
• W3135098981 cites W2120446140 @default.
• W3135098981 cites W2131060185 @default.
• W3135098981 cites W2138871107 @default.
• W3135098981 cites W2146225176 @default.
• W3135098981 cites W2147442832 @default.
• W3135098981 cites W2157076315 @default.
• W3135098981 cites W2159741108 @default.
• W3135098981 cites W2160906692 @default.
• W3135098981 cites W2167383172 @default.
• W3135098981 cites W2168666423 @default.
• W3135098981 cites W2176818153 @default.
• W3135098981 cites W2289682006 @default.
• W3135098981 cites W2315538569 @default.
• W3135098981 cites W2401537340 @default.
• W3135098981 cites W2416914730 @default.
• W3135098981 cites W2562267576 @default.
• W3135098981 cites W2591274003 @default.
• W3135098981 cites W2596733592 @default.
• W3135098981 cites W2756020545 @default.
• W3135098981 cites W2770778260 @default.
• W3135098981 cites W2810579324 @default.
• W3135098981 cites W2885605094 @default.
• W3135098981 cites W2890521354 @default.
• W3135098981 cites W3005961896 @default.
• W3135098981 cites W4294541781 @default.
• W3135098981 doi "https://doi.org/10.1164/rccm.202008-3093oc" @default.
• W3135098981 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33689671" @default.
• W3135098981 hasPublicationYear "2021" @default.
• W3135098981 type Work @default.
• W3135098981 sameAs 3135098981 @default.
• W3135098981 citedByCount "19" @default.
• W3135098981 countsByYear W31350989812021 @default.
• W3135098981 countsByYear W31350989812022 @default.
• W3135098981 countsByYear W31350989812023 @default.
• W3135098981 crossrefType "journal-article" @default.
• W3135098981 hasAuthorship W3135098981A5004691068 @default.
• W3135098981 hasAuthorship W3135098981A5006650120 @default.
• W3135098981 hasAuthorship W3135098981A5009091055 @default.
• W3135098981 hasAuthorship W3135098981A5010100677 @default.
• W3135098981 hasAuthorship W3135098981A5017089109 @default.
• W3135098981 hasAuthorship W3135098981A5019589703 @default.
• W3135098981 hasAuthorship W3135098981A5044514129 @default.
• W3135098981 hasAuthorship W3135098981A5051732204 @default.
• W3135098981 hasAuthorship W3135098981A5058325633 @default.
• W3135098981 hasAuthorship W3135098981A5062525504 @default.
• W3135098981 hasAuthorship W3135098981A5065857269 @default.
• W3135098981 hasAuthorship W3135098981A5069296013 @default.
• W3135098981 hasAuthorship W3135098981A5073728339 @default.
• W3135098981 hasAuthorship W3135098981A5080609457 @default.
• W3135098981 hasAuthorship W3135098981A5082568705 @default.
• W3135098981 hasAuthorship W3135098981A5086014788 @default.
• W3135098981 hasAuthorship W3135098981A5088823841 @default.
• W3135098981 hasAuthorship W3135098981A5089726431 @default.
• W3135098981 hasBestOaLocation W31350989812 @default.
• W3135098981 hasConcept C104317684 @default.
• W3135098981 hasConcept C126322002 @default.
• W3135098981 hasConcept C137061746 @default.
• W3135098981 hasConcept C143998085 @default.
• W3135098981 hasConcept C150194340 @default.
• W3135098981 hasConcept C162317418 @default.
• W3135098981 hasConcept C165637977 @default.
• W3135098981 hasConcept C202751555 @default.

• next